Importance Very short mandatory dual antiplatelet therapy (DAPT) after percutaneous coronary
intervention (PCI) with a drug-eluting stent may be an attractive option. Objective To test …

Background Scarce data exist about the outcomes after percutaneous coronary intervention
( PCI ) in old patients. This study sought to provide an overview of PCI in elderly patients, …

Background We aimed to evaluate the feasibility of an oral direct thrombin inhibitor, dabigatran,
as a periprocedural anticoagulant for use with ablation of atrial fibrillation (AF). Methods …

Background Experimental studies have suggested that dipeptidyl peptidase-4 (DPP-4) inhibitors
provide cardiovascular protective effects. We performed a randomized study to evaluate …

Previously we briefly reported the effect of 1-month dual antiplatelet therapy (DAPT) for patients
with high bleeding risk (HBR) receiving percutaneous coronary intervention (PCI) in the …

Background Diabetes is associated closely with an increased risk of cardiovascular events,
including diastolic dysfunction and heart failure that leads to a shortening of life expectancy. …

CORRESPONDENCE than those in the non-HBR group. High-risk features of stent-driven
recurrent ischemia from the 2017 European Society of Cardiology focused update on DAPT …

Background: Given the characteristic differences between intravascular ultrasound (IVUS)
and optical frequency domain imaging (OFDI), their approach to therapeutic guidance during …

This study aims to elucidate 1-year clinical outcomes using this technique for patients with
stage 4 or 5 advanced chronic kidney disease (CKD). Research has proven that imaging-…

Background Despite its recommendation by the current guidelines, the role of long-term oral
beta-blocker therapy has never been evaluated by randomized trials in uncomplicated ST-…